Verapamil for Neuroprotection in Stroke

Recruiting now · Phase 1/Phase 2

Conditions studied: Ischemic Stroke

In brief

The purpose of this research study is to test an experimental procedure called intra-arterial delivery of verapamil in patients diagnosed with acute ischemic stroke. This study investigates the safety of intra-arterial delivery of verapamil, a drug used to treat vasospasm (spasm of a blood vessel), and how it affects recovery from stroke. Recruitment is limited to patients that have received mechanical thrombectomy as standard of care.

Key facts

Study ID
NCT03347786
Run by
Global Neurosciences Institute
People needed
60
Starts
2017-04-20
Expected to finish
2026-12-01
Last updated by the study team
2025-01-17

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.